Revenue Growth - The group's revenue increased from approximately HKD 4,103,000 for the three months ended March 31, 2022, to approximately HKD 17,886,000 for the three months ended March 31, 2023, representing a growth of about 336%[29] - Revenue for the three months ended March 31, 2023, was HKD 17,886,000, a significant increase from HKD 4,103,000 in the same period of 2022, representing a growth of 336%[35] - Total revenue for the group reached HKD 17,886,000, representing a 336% increase from HKD 4,103,000 in the prior year[101] Photography Service Revenue - Photography service revenue surged over six times to approximately HKD 15,641,000 for the three months ended March 31, 2023, compared to HKD 2,393,000 for the same period in 2022[29] - For the three months ended March 31, 2023, the group reported photography service revenue of HKD 15,641,000, a significant increase of 554% compared to HKD 2,393,000 for the same period in 2022[101] - The increase in profit was primarily due to the relaxation of certain social distancing and entry-exit control measures at the end of 2022, leading to increased revenue in the photography service business[29] Medical Service Revenue - Medical service revenue was approximately HKD 2,245,000 for the three months ended March 31, 2023, up from HKD 1,710,000 for the same period in 2022, maintaining a relatively stable level[29] - Medical service revenue for the same period was HKD 2,245,000, up 31% from HKD 1,710,000 in the previous year[101] - The company is actively seeking to expand its medical services business by recruiting suitable practitioners and exploring related business opportunities[115] Profitability and Loss - The profit attributable to equity shareholders increased from a loss of approximately HKD 3,735,000 for the three months ended March 31, 2022, to a profit of approximately HKD 2,003,000 for the same period in 2023[29] - Gross profit for the same period was HKD 6,042,000, compared to a gross loss of HKD 901,000 in 2022, indicating a turnaround in profitability[35] - Operating profit for the quarter was HKD 2,017,000, a recovery from an operating loss of HKD 3,732,000 in the previous year[35] - Total comprehensive income for the period was HKD 1,865,000, recovering from a total comprehensive loss of HKD 3,909,000 in the prior year[36] - The group reported a total comprehensive loss of approximately HKD 1,256,000 for the three months ended March 31, 2023[15] Expenses and Costs - The total expenses for the group were approximately HKD 2,858,000 for the three months ended March 31, 2023[15] - Administrative expenses increased to HKD 4,530,000 from HKD 4,173,000, reflecting a rise of 8.5% year-over-year[35] - The company incurred finance costs of HKD 141,000, slightly up from HKD 131,000 in the previous year[35] - The foreign exchange loss from the translation of financial statements of subsidiaries outside Hong Kong was HKD 76,000, compared to a loss of HKD 45,000 in the same period last year[36] Shareholder Information - The board did not recommend the declaration of any interim dividend for the three months ended March 31, 2023[29] - There were no interim dividends recommended for the three months ended March 31, 2023[88] - The company has maintained a commitment to act in the best interests of its shareholders, with a board comprising seven members, including three independent non-executive directors[174] Financial Position - The total equity of the group as of March 31, 2023, was approximately HKD 24,579,000, down from HKD 30,638,000 a year earlier[123] - Cash and cash equivalents totaled approximately HKD 18,486,000, a decrease from HKD 24,236,000 as of March 31, 2022[123] - As of March 31, 2023, the company's debt-to-equity ratio was 47.62%, slightly up from 47.52% on March 31, 2022[153] Business Development and Strategy - The company aims to expand its service locations in Hong Kong to enhance its market presence[29] - The group has successfully won a government tender to provide automated photography services for identity documents, effective from March 1, 2023, for a duration of 24 months, which is expected to enhance revenue and profitability[92] - The group is reallocating resources to upgrade and maintain its automated photography machines and to enhance media advertising and promotional activities[93] - The company plans to allocate more resources to optimize its business model and diversify its core business, particularly in the IT infrastructure sector[128] - The company has initiated the development of medical services, including the establishment or acquisition of new clinics[129] - The board has decided to reallocate unutilized net proceeds from the share sale to further develop the self-service photo booth business in Hong Kong and to invest in medical-related services[196] Employee and Workforce - The group had 78 employees as of March 31, 2023, compared to 51 employees a year earlier, indicating growth in workforce[138] Financing and Capital - The company secured a bank loan of approximately HKD 2,000,000 as of March 31, 2023, compared to none a year earlier[138] - The company had bank financing secured by restricted bank deposits amounting to HKD 5,000,000 as of March 31, 2023, compared to zero on March 31, 2022[157] - The company raised approximately HKD 62,000,000 from the sale of 200,000,000 shares at HKD 0.31 per share, with a net amount of about HKD 31,852,000 as of March 31, 2023[176] Audit and Compliance - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited consolidated results for the quarter ending March 31, 2023, ensuring compliance with applicable accounting standards[175] Competition and Market Position - The company has not disclosed any significant competition or conflicts of interest involving its directors or major shareholders as of March 31, 2023[175] - The company has not reported any new product developments or market expansions in the current quarter[156]

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本 公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確 表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引 致的任何損失承擔任何責任。 本公告載有遵照聯交所GEM證券上市規則（「GEM上市規則」）提供的詳情， 旨在提供關於名仕快相集團控股有限公司（「本公司」，連同其附屬公司， 統稱「本集團」或「我們」）的資料，本公司董事（「董事」）就此共同及個別地 承擔全部責任。董事經作出一切合理查詢後確認，就彼等所深知及確信， 本公告所載資料在所有重大方面均屬準確及完整，並無誤導或欺詐成分， 且本公告並無遺漏任何其他事宜導致當中任何陳述或本公告具誤導成分。 Max Sight Photo (cid:8907)(cid:7571)(cid:11945)(cid:17846) Max Sight Group Holdings Limited 名 仕 快 相 集 團 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：8483） 截 至 二 零 二 三 年 三 月 三 十 一 日 止 三 個 月 第 一 季 度 業 績 公 ...

Share Option Scheme - No stock options were granted, lapsed, exercised, or cancelled under the share option scheme for the year ended December 31, 2022[1]. - The share option scheme aims to encourage eligible individuals to contribute to the group and reward past contributions, helping to attract and retain experienced personnel[2]. - The maximum number of shares to be issued upon exercise of options under the scheme shall not exceed 10% of the issued shares at any time[5]. - The subscription price for any specific option is determined by the board at the time of grant and cannot be lower than the higher of the share's par value, the closing price on the offer date, or the average closing price over the five trading days preceding the offer date[7]. - The share option scheme is effective for ten years from the listing date, but shareholders can terminate it at any time[9]. - As of December 31, 2022, no other share option schemes have been adopted by the company[10]. - The company has not entered into any equity-linked agreements that would lead to the issuance of shares during the year or at year-end[11]. Shareholding Structure - Mr. Chan Wing Chai and Mr. Chan Tin Ki each hold 427,600,560 shares, representing 53.45% of the issued shares through Causeway Treasure[13]. - The disclosed interests in Causeway Treasure indicate that Mr. Chan Wing Chai and Mr. Chan Tin Ki each own approximately 47.25% of the entity[15]. - No directors or senior management held any interests in the company's shares or related securities as of December 31, 2022, apart from those disclosed[16]. - As of December 31, 2022, Causeway Treasure holds 427,600,560 shares, representing approximately 53.45% of the company's equity[19]. - Me Group International Plc. owns 109,972,500 shares, accounting for 13.75% of the company's equity[19]. - Mr. Zhang Gan Ting holds 62,426,940 shares, which is 7.80% of the company's equity[19]. Financial Performance - For the year ended December 31, 2022, the group's revenue increased by approximately HKD 10,300,000 to about HKD 31,253,000, representing a growth of approximately 49.2% compared to the previous year[77]. - Total revenue for the year ended December 31, 2022, was approximately HKD 31,253,000, with a loss attributable to equity shareholders of approximately HKD 11,518,000, an increase of about HKD 4,110,000 from the previous year[89]. - Service costs increased from approximately HKD 15,769,000 for the year ended December 31, 2021, to approximately HKD 26,175,000 for the year ended December 31, 2022, representing an increase of about 66%[100]. - Other income rose from approximately HKD 1,436,000 for the year ended December 31, 2021, to approximately HKD 2,073,000 for the year ended December 31, 2022, an increase of about 45%[78]. - Administrative expenses increased by approximately HKD 2,553,000 due to higher employee costs and director remuneration related to the launch of medical services in Hong Kong[83]. - The group’s gross profit for the year ended December 31, 2022, was approximately HKD 5,078,000, with a gross profit margin of about 16.25%, down from HKD 5,184,000 and 24.74% in the previous year[119]. - Administrative expenses increased from approximately HKD 14,043,000 to HKD 16,596,000, primarily due to higher employee costs and director remuneration[120]. - As of December 31, 2022, the group reported a total equity of approximately HKD 22,714,000, down from HKD 34,542,000 as of December 31, 2021[125]. - The group's cash and cash equivalents totaled approximately HKD 21,699,000 as of December 31, 2022, compared to HKD 30,741,000 as of December 31, 2021[125]. - The group has no significant investments or future plans for major investments as of December 31, 2022[115]. Business Operations - Photography service revenue rose by approximately 15.02% to about HKD 23,362,000 for the year ended December 31, 2022, up from HKD 20,311,000 in the previous year[77]. - Medical services revenue reached approximately HKD 7,891,000 for the year ended December 31, 2022, a significant increase from HKD 642,000 in the previous year, following the launch of medical services in October 2021[77]. - The medical services business contributed approximately 25.2% to the group's total revenue as of December 31, 2022[50]. - The group has been awarded a contract by the Hong Kong government to provide automated photography services for identity documents, effective from March 1, 2023, for a duration of 24 months[69]. - The group plans to upgrade and maintain its self-service digital photo machines, which may become a new direction for future business development[67]. - The group is actively seeking opportunities to expand its medical services by recruiting suitable practitioners and acquiring new clinics and related businesses[75]. - The group has terminated leases for underperforming photo service locations as a cost control measure[73]. - The group aims to diversify its core business by reallocating resources towards information technology infrastructure to optimize its business model[74]. - The group anticipates that the demand for identity document photos will improve in the foreseeable future due to the easing of travel restrictions and social distancing measures[71]. - The group operates self-service digital photography services in Hong Kong and Guangdong Province, China, focusing on identity verification and medical services[149]. Risk Management - The company is subject to significant market volatility risks due to its listing on the GEM[34]. - The group’s financial condition and operational performance may be influenced by various risks and uncertainties related to its business[153]. - The group faces currency risk primarily from cash and bank balances held in USD and RMB, with revenue and expenses mainly denominated in RMB and HKD[160]. - The company relies on a professional team for its medical services, which could adversely affect financial performance if qualified professionals are not recruited or retained[179]. - The group’s business model in medical services depends on consultant or employment arrangements, which can be terminated with notice[179]. - The company’s reputation and brand image in medical services may be negatively impacted by any negligence or legal issues, affecting business and financial performance[180]. Corporate Governance - The board of directors has collectively confirmed the accuracy and completeness of the annual report[35]. - The company has confirmed compliance with non-competition agreements during the restricted period[27]. - The company has no preferential rights provisions requiring it to offer new shares to existing shareholders on a pro-rata basis[24]. - The group has established a remuneration committee to review the compensation policies and structures for directors and senior management, considering operational performance and market practices[197]. - The group emphasizes the importance of employees as valuable assets and complies with Hong Kong labor laws while regularly reviewing employee benefits[158]. - The group has established standard operating procedures for its medical centers to minimize the risk of medical negligence[156]. Dividend Policy - The company will not declare any final dividend for the year ended December 31, 2022, to maintain sufficient funds for future business development[90]. - The group did not recommend the declaration of a final dividend for the year ending December 31, 2022[151]. - The board does not recommend declaring an interim dividend for the years ended December 31, 2022, and December 31, 2021[163]. - As of December 31, 2022, the company's distributable reserves were approximately HKD 13,378,000, with no final dividend declared for the year[191]. Financing and Capital Structure - Financing costs for lease liabilities and bank loans were approximately HKD 454,000 and HKD 423,000 for the years ended December 31, 2022, and 2021, respectively[81]. - As of December 31, 2022, the group had a debt-to-asset ratio of 51.5%, an increase from 42.2% in the previous year[125]. - The group had outstanding bank loans of approximately HKD 1,000,000 as of December 31, 2022[192]. - As of December 31, 2022, the group's bank financing included restricted bank deposits amounting to HKD 5,000,000, compared to zero in the previous year[161].

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而 引致的任何損失承擔任何責任。 本公告載有遵照聯交所GEM證券上市規則（「GEM上市規則」）提供的詳情，旨在提供關於名仕快相集團控 股有限公司（「本公司」）的資料，本公司董事（「董事」）就此共同及個別地承擔全部責任。董事經作出一切合 理查詢後確認，就彼等所深知及確信，本公告所載資料在所有重大方面均屬準確及完整，並無誤導或欺詐 成分，且本公告並無遺漏任何其他事宜導致當中任何陳述或本公告具誤導成分。 Max Sight Photo Max Sight Group Holdings Limited 名 仕 快 相 集 團 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：8483） 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 年 度 業 績 公 告 聯 交 所 GEM 的 特 色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所上市 的公司帶有較高投資風險。有 ...

Revenue and Profitability - The group's revenue increased from approximately HKD 15,131,000 for the nine months ended September 30, 2021, to approximately HKD 20,154,000 for the nine months ended September 30, 2022, representing an increase of about 33.3%[6] - The group's gross profit for the nine months ended September 30, 2022, was approximately HKD 1,101,000, with a gross profit margin of about 5.46%, compared to a gross profit of HKD 4,373,000 and a margin of 28.90% for the same period in 2021[6] - The total revenue for the nine months ended September 30, 2022, was HKD 20,154 thousand, compared to HKD 15,131 thousand in 2021, marking a 33.2% increase[27] - The reported segment profit for photography services was HKD 3,697,000, while medical services reported a loss of HKD 5,225,000, leading to an overall segment loss of HKD 765,000[30] - The service cost rose from approximately HKD 10,758,000 to approximately HKD 19,053,000, an increase of about 77% due to higher employee costs, physician fees, medical supplies, and depreciation[54] - Gross profit decreased from approximately HKD 4,373,000 to approximately HKD 1,101,000, with gross margin dropping from 28.90% to 5.46% due to increased service costs[55] Losses and Expenses - Loss attributable to equity shareholders increased from approximately HKD 4,467,000 for the nine months ended September 30, 2021, to approximately HKD 8,508,000 for the same period in 2022, primarily due to reduced gross profit and increased administrative expenses[6] - Administrative expenses rose to approximately HKD 12,591,000 for the nine months ended September 30, 2022, compared to HKD 9,972,000 for the same period in 2021, driven by increased employee costs and director remuneration[6] - Operating loss for the nine months ended September 30, 2022, was approximately HKD 8,909,000, compared to HKD 4,233,000 for the same period in 2021[14] - The group reported a net loss of approximately HKD 9,223,000 for the nine months ended September 30, 2022, compared to a net loss of HKD 4,484,000 for the same period in 2021[14] - Total comprehensive loss for the nine months ended September 30, 2022, was HKD (8,601) thousand, compared to HKD (4,587) thousand for the same period in 2021, representing a 87.5% increase in loss[15] Medical Services - Medical services revenue amounted to approximately HKD 4,794,000 for the nine months ended September 30, 2022, with no revenue reported for the same period in 2021, following the launch of medical services in Hong Kong[6] - The company continues to expand its service offerings by providing medical services through medical centers in Hong Kong since October 2021[19] - The medical services business was launched in October 2021, with the company actively seeking to expand by recruiting suitable medical professionals and acquiring necessary equipment[50] - The company plans to invest in upgrading medical equipment and software to enhance the quality and reliability of its medical services[50] Shareholder Information - The company does not recommend the declaration of any interim dividend for the nine months ended September 30, 2022[6] - The total comprehensive loss attributable to equity shareholders of the company was HKD (7,886) thousand for the nine months ended September 30, 2022, compared to HKD (4,570) thousand in 2021, reflecting a 72.5% increase[15] - The company’s major shareholders, Causeway Treasure, holds 427,600,560 shares, representing approximately 53.45% of the total issued shares[88] - Both Mr. Chen Yongji and Mr. Chen Tianqi own 427,600,560 shares in Causeway Treasure, each holding approximately 53.45% of the total issued shares[82] Operational Challenges and Future Outlook - The photography services revenue was weak due to the fifth wave of COVID-19 and travel restrictions, leading to a significant decline in demand for identity photos[45] - The company anticipates that the demand for identity photos in Hong Kong will recover in the near future as travel restrictions are lifted and vaccination rates increase[45] - The company has terminated leases for underperforming photo booth locations as a cost-control measure, reflecting a prudent approach to managing financial performance[48] - The economic impact of COVID-19 remains uncertain, and the company continues to monitor its effects on financial performance[48] - The company is taking a cautious approach to expanding its self-service photo booth business in Guangdong Province due to ongoing pandemic challenges[47] Financial Management and Governance - The company’s financial statements are prepared in accordance with Hong Kong Financial Reporting Standards, ensuring compliance with relevant regulations[21] - The company has established a remuneration committee to review the remuneration policies and structures for directors and senior management, with 56 employees as of September 30, 2022, compared to 37 employees a year earlier[66] - The company has established an audit committee in accordance with GEM listing rules to oversee financial reporting and risk management[96] - The audit committee reviewed the unaudited consolidated results for the nine months ended September 30, 2022, and found them compliant with applicable accounting standards and regulations[96] Investment and Funding - The company raised approximately HKD 62 million from the sale of 200,000,000 shares at HKD 0.31 per share, with a net amount of approximately HKD 31.85 million[98] - As of September 30, 2022, approximately HKD 14.53 million of the net proceeds had been utilized, with HKD 17.33 million remaining unutilized[99] - The company plans to allocate approximately HKD 17.9 million of the unutilized net proceeds to develop its medical services and related equipment, as well as to establish or acquire new clinics[101] - All unutilized proceeds have been deposited in a licensed bank in Hong Kong as of the report date[102] Compliance and Conduct - The company has adopted the GEM Listing Rules as its code of conduct for securities trading by directors, confirming compliance as of September 30, 2022[78] - The company has confirmed that there are no conflicts of interest among its directors as of September 30, 2022[93] - There are no undisclosed interests or positions held by directors or senior management in the company or its associated corporations as of September 30, 2022[86]

Revenue and Business Segments - The group's revenue increased from approximately HKD 9,232,000 for the six months ended June 30, 2021, to approximately HKD 11,455,000 for the six months ended June 30, 2022, representing an increase of about 24.0%[6] - Medical services revenue was approximately HKD 3,016,000 for the six months ended June 30, 2022, which was not present in the same period in 2021, indicating a new business segment launched in October 2021[6] - The group operates three reportable segments: photography services in Hong Kong, photography services in Mainland China, and medical services in Hong Kong[36] - The revenue from external customers in Hong Kong was HKD 10,951,000, an increase from HKD 8,535,000 in the previous year, while revenue from mainland China decreased to HKD 504,000 from HKD 697,000[40] - The company continues to focus on expanding its medical services, which began in October 2021, indicating a strategic shift towards healthcare[33] Financial Performance - Loss attributable to equity shareholders increased from approximately HKD 3,050,000 for the six months ended June 30, 2021, to approximately HKD 6,434,000 for the six months ended June 30, 2022, primarily due to increased gross loss and administrative expenses[6] - The total comprehensive loss for the six months ended June 30, 2022, was HKD 6,702,000, compared to a loss of HKD 3,133,000 for the same period in 2021, representing an increase in loss of 114%[12] - The basic and diluted loss per share for the period was HKD 0.80, compared to HKD 0.38 in the previous year, indicating a 105% increase in loss per share[12] - The group reported a loss before tax of approximately HKD 6,960,000 for the six months ended June 30, 2022, compared to HKD 3,081,000 for the same period in 2021[11] - The company reported a pre-tax loss of HKD 6,960,000 for the period, compared to a pre-tax loss of HKD 3,081,000 in the prior year[37] Operating Expenses - The group's gross loss and gross profit for the six months ended June 30, 2022, were approximately HKD 497,000 and HKD 2,161,000, respectively, with gross loss margin and gross profit margin at approximately 4.34% and 23.41%[6] - Administrative expenses increased due to higher employee costs and director remuneration associated with the medical services business launched in Hong Kong[6] - The total operating expenses, including headquarters and corporate costs, amounted to HKD 5,393,000, compared to HKD 5,825,000 in the previous year[37] - Administrative expenses rose from approximately HKD 6,320,000 for the six months ended June 30, 2021, to approximately HKD 8,245,000 for the six months ended June 30, 2022, an increase of about 30.5%[82] Assets and Liabilities - Non-current assets increased to HKD 29,471,000 as of June 30, 2022, from HKD 26,496,000 as of December 31, 2021, reflecting an increase of 11.8%[14] - Current assets decreased to HKD 25,631,000 as of June 30, 2022, from HKD 33,291,000 as of December 31, 2021, a decline of 23.1%[14] - The company’s total liabilities increased to HKD 14,603,000 as of June 30, 2022, from HKD 14,856,000 as of December 31, 2021, a decrease of 1.7%[15] - The company’s equity attributable to shareholders decreased to HKD 28,622,000 as of June 30, 2022, from HKD 34,784,000 as of December 31, 2021, a decline of 17.7%[15] - The company’s inventory increased to HKD 533,000 as of June 30, 2022, from HKD 148,000 as of December 31, 2021, an increase of 259.5%[14] Employee and Workforce - As of June 30, 2022, the group had 65 employees, an increase from 36 employees as of June 30, 2021, representing an 81.25% growth in workforce[89] - The total employee costs reached HKD 6,654,000, up from HKD 4,293,000 in the previous year, reflecting a 55% increase[43] Corporate Governance and Compliance - The financial statements were prepared in accordance with Hong Kong Financial Reporting Standards and have been reviewed by the audit committee[28] - The audit committee has reviewed the unaudited consolidated results for the six months ended June 30, 2022, ensuring compliance with applicable accounting standards and regulations[119] - The company has complied with all applicable provisions of the corporate governance code during the six months ended June 30, 2022[99] Future Plans and Strategic Initiatives - The group is exploring opportunities to diversify its business and is reallocating resources to optimize its business model for future growth[74] - The group plans to adopt a more cautious approach in executing its expansion plans in mainland China due to the ongoing COVID-19 situation and market volatility[70] - The company is actively seeking to recruit suitable medical professionals and expand its medical services business through new clinics and related operations[125] Impact of COVID-19 - The company reported a significant impact on financial performance due to the ongoing COVID-19 pandemic, with further economic conditions remaining uncertain[67] - Photography service revenue decreased by approximately 8.59% to about HKD 8,439,000 for the six months ended June 30, 2022, compared to HKD 9,232,000 for the same period in 2021, primarily due to reduced travel demand caused by the COVID-19 pandemic[76] - The company has delayed its original plan to expand the digital photo booth network in Guangdong due to challenges posed by the COVID-19 pandemic and the Omicron variant outbreak[125] Share Capital and Major Shareholders - The issued share capital of the company remained unchanged since its listing date, with a total of 800,000,000 shares issued[88] - The major shareholders, Mr. Chan Wing Chai and Mr. Chan Tin Ki, each hold 53.45% of the company's shares[104] - As of June 30, 2022, Causeway Treasure holds 427,600,560 shares, representing approximately 53.45% of the company's equity[111] - Photo-Me holds 109,972,500 shares, accounting for 13.75% of the company's equity[111] Use of Proceeds - The company raised approximately HKD 62.0 million from the sale of 200,000,000 shares at HKD 0.31 per share[120] - As of June 30, 2022, approximately HKD 12.9 million of the net proceeds has been utilized, with HKD 19.0 million remaining[123] - The company plans to use HKD 6.1 million for the development of its self-service identity photo digital camera business by December 31, 2023[123] - An allocation of HKD 4.6 million is designated for purchasing equipment for medical and related services by December 31, 2023[123] - The company aims to establish or acquire new clinics and medical-related businesses with an allocation of HKD 2.0 million by December 31, 2023[123] - Upgrading verification centers and IT infrastructure has an allocation of HKD 2.0 million, with HKD 0.9 million already utilized[123] - General working capital has an allocation of HKD 10.2 million, with HKD 5.0 million already utilized[123]

Financial Performance - The group's revenue decreased by approximately HKD 327,000 to about HKD 4,103,000 for the three months ended March 31, 2022, compared to HKD 4,430,000 for the same period in 2021[6]. - Photography service revenue dropped by approximately 45.98% to about HKD 2,393,000 for the three months ended March 31, 2022, down from HKD 4,430,000 for the same period in 2021[6]. - Medical services revenue was approximately HKD 1,710,000 for the three months ended March 31, 2022, starting from October 2021 when the company began operating medical centers in Hong Kong[6]. - The company's revenue decreased from approximately HKD 4,430,000 for the three months ended March 31, 2021, to approximately HKD 4,103,000 for the three months ended March 31, 2022, a decline of about 7.38%[46]. - Revenue from photography services for the three months ended March 31, 2022, was HKD 2,393 thousand, down 46% from HKD 4,430 thousand in the same period of 2021[24]. - Revenue from medical services for the three months ended March 31, 2022, was HKD 1,710 thousand, with no revenue reported in the same period of 2021[24]. - Total revenue for the group for the three months ended March 31, 2022, was HKD 4,103 thousand, a decrease of 7% compared to HKD 4,430 thousand in the same period of 2021[24]. - Revenue from Hong Kong was HKD 3,831 million, down 6.0% from HKD 4,074 million year-on-year[30]. - Revenue from Mainland China was HKD 272 million, a decline of 23.6% compared to HKD 356 million in the previous year[30]. Loss and Expenses - The group's gross loss and gross profit for the three months ended March 31, 2022, were approximately HKD 901,000 and HKD 421,000, respectively, with gross loss margin and gross profit margin at approximately 21.96% and 9.50%[6]. - Loss attributable to equity shareholders increased by approximately HKD 2,062,000 to about HKD 3,735,000 for the three months ended March 31, 2022, compared to HKD 1,673,000 for the same period in 2021[6]. - Operating loss for the three months ended March 31, 2022, was approximately HKD 3,732,000, compared to HKD 1,616,000 for the same period in 2021[11]. - The company reported a net loss of HKD 3,864,000 for the three months ended March 31, 2022, compared to HKD 1,673,000 for the same period in 2021[11]. - The total comprehensive loss for the three months ended March 31, 2022, was HKD (3,909) thousand, compared to a loss of HKD (1,668) thousand in the same period of 2021[12]. - Basic and diluted loss per share for the period was HKD (0.47), compared to HKD (0.21) in the previous year[12]. - The group reported a loss before tax of HKD 3,863 million for the quarter, compared to a loss of HKD 1,692 million in the same period last year[30]. - The company reported a loss attributable to equity shareholders of approximately HKD 3,735,000 for the three months ended March 31, 2022, up from HKD 1,673,000 for the same period in 2021, marking an increase of about 123.56%[55]. Impact of COVID-19 - The COVID-19 pandemic has significantly impacted the financial performance and business development of the group, particularly affecting the demand for identity photos[37]. - The increase in loss was primarily due to higher gross loss from the impact of the fifth wave of COVID-19 in Hong Kong and increased administrative expenses due to higher employee costs and director remuneration related to the medical services business[6]. - The management believes that the decline in demand for identity photos is temporary and expects a recovery in the near future as vaccination rates increase[40]. - The group plans to continue monitoring the COVID-19 situation and has taken measures to mitigate its impact on financial conditions and operational performance[41]. - The company has reported delays in business development in Guangdong Province and Hong Kong due to the COVID-19 pandemic and macroeconomic uncertainties[97]. Administrative and Operational Changes - Administrative expenses increased from approximately HKD 3,130,000 for the three months ended March 31, 2021, to approximately HKD 4,173,000 for the same period in 2022, an increase of about 33.33%[52]. - The company has terminated underperforming lease agreements for photo booths as a cost-control measure[41]. - The company is reallocating more funds and resources towards IT infrastructure to optimize its business model and achieve diversification in core operations[43]. - The company is enhancing its IT capabilities to meet future business trends and customer demands, including upgrading its IT infrastructure and payment systems[96]. Medical Services Expansion - The company is expanding its medical services business, aiming to further develop its medical network in Hong Kong by the end of 2022[44]. - The company has initiated various outreach vaccination services to provide flexible vaccination channels to the public[44]. - The company is actively recruiting suitable practitioners and locations to expand its medical services business further[44]. - The company commenced providing medical services through medical centers in Hong Kong starting October 2021[22]. Corporate Governance and Compliance - The company has maintained compliance with all applicable corporate governance codes as of March 31, 2022[69]. - All directors confirmed compliance with the trading standards for securities transactions during the three months ending March 31, 2022[70]. - The audit committee has reviewed the unaudited consolidated results for the three months ended March 31, 2022, confirming compliance with applicable accounting standards and GEM listing rules[91]. Shareholder Information - The major shareholder, Causeway Treasure, holds approximately 53.45% of the company's shares[83]. - The company has not declared any interim dividend for the periods ended March 31, 2022, and March 31, 2021[33]. - The company has not made any significant investments or future plans regarding major investments and capital assets as of March 31, 2022[62]. - There were no major acquisitions or disposals of subsidiaries, associates, or joint ventures during the period ending March 31, 2022[63]. - The company has not pledged any assets as of March 31, 2022[64]. - There are no significant contingent liabilities reported as of March 31, 2022[65]. - The company did not purchase, sell, or redeem any of its listed securities during the three months ending March 31, 2022[71]. - The company has not disclosed any new product or technology developments, market expansions, or mergers and acquisitions during the reporting period[62][63][64][65]. Utilization of Proceeds - As of March 31, 2022, the company has utilized approximately HKD 10,546,000 of the net proceeds from the share sale, with a remaining unutilized amount of HKD 21,306,000[92]. - The company plans to expand its self-service identity photo digital camera network in Guangdong Province, with HKD 24,381,000 allocated for this purpose, of which HKD 6,652,000 has been used[94]. - The company has reassigned approximately HKD 5,000,000 from the unutilized proceeds for general working capital due to challenges in expanding the self-service identity photo digital camera market in Guangdong Province[97]. - All unutilized proceeds are currently held in a licensed bank in Hong Kong[99].

Financial Performance - For the fiscal year ending December 31, 2021, the company generated revenue of approximately HKD 20,953,000, while the attributable loss to owners was about HKD 7,408,000, primarily due to the outbreak of the COVID-19 pandemic[13]. - The group's financial performance deteriorated mainly due to weak revenue for the year ended December 31, 2021, attributed to the COVID-19 pandemic and travel restrictions, leading to a significant decline in demand for identification photos[17]. - The company's revenue increased from approximately HKD 19,979,000 for the year ended December 31, 2020, to approximately HKD 20,953,000 for the year ended December 31, 2021, representing an increase of about 4.9%[31]. - Photography service revenue slightly rose by approximately 1.7% to about HKD 20,311,000 for the year ended December 31, 2021, compared to HKD 19,979,000 in 2020[31]. - Medical services revenue was approximately HKD 642,000 for the year ended December 31, 2021, compared to none in 2020, indicating the commencement of medical service operations[31]. - Gross profit increased to approximately HKD 5,184,000 for the year ended December 31, 2021, with a gross profit margin of about 24.74%, up from HKD 1,757,000 and a margin of 8.79% in 2020[33]. - Administrative expenses rose from approximately HKD 11,813,000 in 2020 to about HKD 14,043,000 in 2021, an increase of about 18.9% primarily due to higher employee costs[36]. - The loss attributable to equity shareholders increased from approximately HKD 4,478,000 in 2020 to about HKD 7,408,000 in 2021, reflecting a rise of approximately 65.4%[42]. Business Expansion and Diversification - The company has expanded its business portfolio by launching medical services in October 2021, operating four medical centers in Hong Kong, and plans to establish more centers by the end of 2022[12]. - The company is reallocating resources to enhance its IT infrastructure and optimize its business model, aiming for diversification in its core photography services[11]. - The company aims to explore new business opportunities for sustainable growth and to create long-term value for shareholders[12]. - The group established four subsidiaries to launch its medical services business in Hong Kong as of December 31, 2021, employing approximately 24 staff and professionals[18]. - The company is actively recruiting suitable practicing doctors and locations to further expand its medical services business[31]. - The company is exploring opportunities in Guangdong Province and other regions in mainland China to expand its self-service identity photo digital kiosk network[58]. - The company has registered four subsidiaries to develop its medical services business as part of its diversification strategy[31]. Impact of COVID-19 - The ongoing COVID-19 pandemic has introduced additional uncertainties in the photography service market and operational environment[11]. - The group has faced challenges due to the ongoing COVID-19 pandemic and changing government policies in mainland China affecting its business operations[28]. - The group has taken measures to mitigate the impact of the pandemic, including seeking fee reductions and better terms from suppliers[17]. - The demand for identification photos is expected to recover as the COVID-19 situation improves, with the group actively monitoring the pandemic's impact on its financial performance[23]. - The company is closely monitoring the ongoing COVID-19 situation and its potential impact on financial performance and operational results[68]. Corporate Governance and Compliance - The company has adopted high standards of corporate governance practices as detailed in the annual report[176]. - The group has complied with all relevant laws and regulations, with no significant violations reported that could impact business operations[105]. - The board of directors consists of three executive directors, two non-executive directors, and three independent non-executive directors as of the report date[188]. - The company has established a board diversity policy to enhance performance by considering various factors such as gender, age, cultural background, and professional experience[190]. - The board aims to nominate at least one female candidate for board membership within the next two financial years to improve gender diversity[191]. - The company has implemented appropriate liability insurance for directors, which is reviewed annually[187]. - The company confirmed compliance with the non-competition agreements established by major shareholders for the year ended December 31, 2021[165]. Future Outlook and Strategic Initiatives - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share by 2025[75]. - New product launches are expected to contribute an additional HKD 300 million in revenue over the next fiscal year[74]. - The company is investing HKD 50 million in R&D for new imaging technologies, aiming to enhance product offerings[78]. - A strategic acquisition of a local competitor is anticipated to be finalized by Q2 2024, expected to increase market penetration by 10%[79]. - The company has set a performance guidance of 10% revenue growth for the upcoming fiscal year[76]. Shareholder Relations and Dividends - The board of directors has decided not to recommend any final dividend for the fiscal year ending December 31, 2021, to maintain sufficient funds for future business development[16]. - The company did not recommend the declaration of any interim or final dividends for the year ended December 31, 2021[69]. - The group has a distributable reserve of approximately HKD 14,357,000 as of December 31, 2021, with no final dividend declared for the year[117]. - The board of directors has approved a dividend payout of HKD 0.10 per share, reflecting a commitment to returning value to shareholders[82]. Operational Efficiency and Risk Management - The company is committed to strengthening its core business while seizing market opportunities for future development[12]. - The company relies on a professional team for its medical services, and any failure to attract or retain qualified professionals could adversely affect financial performance[100]. - The company has established standard operating procedures for its medical centers to minimize risks associated with medical negligence[101]. - The company’s business, operational performance, and financial condition may be impacted by various risks and uncertainties related to its operations[97]. - The group has implemented business continuity plans including "work from home," "flexible hours," and "group arrangements" to mitigate the impact of natural disasters or pandemics on operations[102].

Financial Performance - The group's revenue decreased from approximately HKD 15,924,000 to HKD 15,131,000, a reduction of about HKD 793,000 for the nine months ended September 30, 2021[7]. - Gross profit for the nine months ended September 30, 2021, was approximately HKD 4,373,000, with a gross margin of about 28.90%, compared to a gross profit of HKD 1,117,000 and a margin of 7.01% for the same period in 2020[7]. - Loss attributable to equity shareholders increased from approximately HKD 1,835,000 to HKD 4,467,000, an increase of about HKD 2,632,000 for the nine months ended September 30, 2021[7]. - Other income decreased significantly due to reduced COVID-19 related rent concessions, contributing to the overall revenue decline[7]. - Administrative expenses increased due to higher employee costs, impacting the overall financial performance[7]. - Operating loss for the nine months ended September 30, 2021, was approximately HKD 4,233,000, compared to an operating profit of HKD 1,463,000 for the same period in 2020[15]. - The company reported a net loss of HKD 4,484,000 for the nine months ended September 30, 2021, compared to a net loss of HKD 1,835,000 for the same period in 2020[15]. - Other income for the nine months ended September 30, 2021, was approximately HKD 1,179,000, down from HKD 6,696,000 in the previous year[15]. - The total comprehensive loss for the period was HKD 4,587,000, compared to a total comprehensive loss of HKD 1,948,000 for the same period in 2020, indicating a significant increase of about 135%[18]. - The basic loss per share for the nine months ended September 30, 2021, was HKD 0.56, compared to HKD 0.23 for the same period in 2020, reflecting an increase in loss per share of approximately 143%[18]. - The company reported a total loss of HKD 4,467,000 attributable to equity shareholders for the nine months ended September 30, 2021[56]. - Revenue decreased from approximately HKD 15,924,000 for the nine months ended September 30, 2020, to approximately HKD 15,131,000 for the nine months ended September 30, 2021, a decline of about 4.95%[74]. Revenue Sources - The company’s revenue primarily comes from providing photography services through self-service digital photo booths in Hong Kong and Guangdong Province, China[33]. - Revenue from Hong Kong for the nine months ended September 30, 2021, was HKD 14,098,000, down from HKD 14,860,000 in the previous year[44]. - Revenue from Mainland China for the nine months ended September 30, 2021, was HKD 1,033,000, slightly down from HKD 1,064,000 in the same period of 2020[44]. Expenses and Costs - Administrative expenses rose from approximately HKD 8,946,000 for the nine months ended September 30, 2020, to approximately HKD 9,972,000 for the nine months ended September 30, 2021, an increase of about 11.5% primarily due to increased employee costs[80]. - Service costs for the nine months ended September 30, 2021, included approximately 78.88% of total service costs attributed to rental fees and depreciation of usage rights assets[75]. - Financing costs related to lease liabilities were approximately HKD 258,000 and HKD 359,000 for the nine months ended September 30, 2021, and 2020, respectively, indicating a decrease of about 28%[81]. Business Operations and Strategy - The company has commenced medical business operations after the nine months ended September 30, 2021, indicating a potential expansion into new markets[37]. - The company plans to open more clinics/medical centers in Hong Kong by the end of 2021, having already rented two locations for medical operations[71]. - The company is actively exploring diversification opportunities, including expanding its self-service photo booth network and enhancing its verification center and IT infrastructure[70]. - The company is focused on strengthening its core business while exploring new business opportunities for sustainable growth and increased shareholder value[71]. - The company plans to enhance its IT capabilities to meet future business trends and customer demands, having engaged vendors to upgrade its IT infrastructure, including remote monitoring and electronic payment systems[132]. - Business development in Guangdong Province and Hong Kong has been delayed due to the COVID-19 outbreak and changing policies regarding identification photos in mainland China[135]. - The company will continue to assess and modify existing plans based on recent market conditions to achieve sustainable business growth and long-term shareholder benefits[135]. Shareholder Information - Causeway Treasure holds a total of 427,600,560 shares, representing 53.45% of the company's equity[118]. - The beneficial ownership of Causeway Treasure is divided among Chen Yongji and Chen Tianqi, each holding approximately 47.25%, and Ouyang Yinghe holding about 5.5%[119]. - As of September 30, 2021, Photo-Me holds 109,972,500 shares, accounting for 13.75% of the company's equity[118]. - The Chen family, through Causeway Treasure, collectively holds approximately 53.45% of the company's issued share capital as of September 30, 2021[126]. - The board consists of seven members, including three independent non-executive directors, ensuring proper governance and shareholder interests[123]. Compliance and Governance - The company’s financial statements are prepared in accordance with Hong Kong Financial Reporting Standards, ensuring compliance with local regulations[28]. - The company adhered to all applicable corporate governance codes as of September 30, 2021, demonstrating a commitment to high standards of corporate governance[100]. - The company has established a risk management framework to monitor and manage liquidity risks effectively, ensuring sufficient cash and cash equivalents[89]. - The company has not identified any potential conflicts of interest among its directors and management[123]. Capital and Financing - The company raised approximately HKD 62 million from the sale of 200,000,000 shares at HKD 0.31 per share, with a net amount of approximately HKD 31.85 million[130]. - As of September 30, 2021, approximately HKD 7.84 million of the net proceeds had been utilized, leaving HKD 24.02 million unutilized[131]. - All unutilized proceeds have been deposited in licensed banks in Hong Kong as of the report date[136]. - The company has a credit facility of RMB 5,300,000, which was renewed and expired on June 30, 2021[126]. - The company maintained a cash flow from operating activities to fund its operations, with no interest-bearing borrowings as of September 30, 2021, indicating a strong liquidity position[89]. Employment and Workforce - The number of employees decreased from 53 as of September 30, 2020, to 37 as of September 30, 2021, reflecting a reduction in workforce[88].

Financial Performance - The group's revenue decreased from approximately HKD 11,332,000 for the six months ended June 30, 2020, to approximately HKD 9,232,000 for the six months ended June 30, 2021, a reduction of about HKD 2,100,000[7]. - Gross profit for the six months ended June 30, 2021, was approximately HKD 2,161,000, with a gross margin of 23.41%, compared to a gross profit of HKD 1,505,000 and a gross margin of 13.28% for the same period in 2020[7]. - Loss attributable to equity shareholders decreased from approximately HKD 5,381,000 for the six months ended June 30, 2020, to approximately HKD 3,050,000 for the six months ended June 30, 2021, a reduction of about HKD 2,331,000[7]. - The company reported other income of HKD 1,129,000 for the six months ended June 30, 2021, significantly up from HKD 159,000 in the same period of 2020[17]. - The total comprehensive loss attributable to equity shareholders for the period was HKD 3,133,000, compared to HKD 5,264,000 for the same period in 2020[20]. - Basic and diluted loss per share for the six months ended June 30, 2021, was HKD 0.38, compared to HKD 0.67 for the same period in 2020[20]. - The company reported a pre-tax loss of HKD 3,081,000 for the six months ended June 30, 2021, an improvement from a loss of HKD 5,404,000 in the same period of 2020[30]. - The company reported a comprehensive loss of HKD 3,133,000 for the six months ended June 30, 2021, compared to a loss of HKD 5,264,000 in the same period of 2020[28]. - Total employee costs amounted to HKD 4,293,000 for the first half of 2021, down 10.2% from HKD 4,782,000 in the same period of 2020[81]. - Compensation for directors and key management personnel totaled HKD 2,477,000 for the six months ended June 30, 2021, compared to HKD 2,741,000 for the same period in 2020, reflecting a decrease of about 9.6%[17]. Assets and Liabilities - As of June 30, 2021, the total non-current assets amounted to HKD 8,913,000, a decrease of 18.0% from HKD 10,873,000 as of December 31, 2020[22]. - Current assets totaled HKD 40,668,000, down 9.9% from HKD 44,884,000 as of December 31, 2020[22]. - The company's total equity attributable to shareholders decreased to HKD 39,266,000 from HKD 42,399,000, a decline of 7.4%[25]. - The company recorded a decrease in inventory from HKD 420,000 to HKD 264,000, a reduction of 37.1%[22]. - The total liabilities decreased from HKD 8,502,000 to HKD 6,627,000, a decrease of 22.0%[22]. - Cash and cash equivalents decreased to HKD 38,366,000 from HKD 42,700,000, reflecting a decline of 10.9%[30]. - The net cash used in operating activities was HKD 1,597,000, compared to a net cash used of HKD 1,142,000 in the previous year[30]. - Current liabilities for accrued expenses decreased to HKD 919,000 in the first half of 2021 from HKD 1,432,000 in the same period of 2020, a reduction of 35.8%[91]. Revenue Breakdown - Revenue from Hong Kong was HKD 8,535,000, down from HKD 10,671,000 in 2020, indicating a decrease of about 20.0%[67]. - Revenue from Mainland China increased slightly to HKD 697,000 from HKD 661,000, reflecting a growth of approximately 5.4%[67]. - For the six months ended June 30, 2021, total revenue was HKD 9,232,000, a decrease from HKD 11,332,000 in the same period of 2020, representing a decline of approximately 18.5%[67]. - The decline in revenue was primarily due to reduced demand for identification photos during the COVID-19 outbreak and significant decreases in travel demand due to border control measures implemented since early 2020[115]. Business Strategy and Operations - The company is actively exploring new business opportunities to diversify its operations and broaden revenue sources for sustainable growth[101]. - The company is reassessing its self-service digital photo booth network strategy and seeking new locations with better business development potential after the expiration of licensing contracts[105]. - Management is focusing on upgrading IT infrastructure and verification centers to enhance service capabilities and operational efficiency[111]. - The company plans to apply its successful business model in Hong Kong to mainland China and other countries as part of its future development strategy[104]. - The company is expanding its self-service photo booth network in Guangdong Province and other regions, in collaboration with Guangzhou Zhuoteng Technology Co., Ltd.[177]. - The company has engaged suppliers to upgrade its IT infrastructure, including remote monitoring systems and electronic payment facilities, to meet future business trends and customer demands[177]. - The company is assessing the feasibility of upgrading its verification systems and IT infrastructure in Hong Kong and mainland China[177]. Compliance and Governance - The financial statements were prepared in accordance with the GEM Listing Rules and have been reviewed by the audit committee[43]. - The audit committee has reviewed the unaudited consolidated results for the six months ended June 30, 2021, and confirmed compliance with applicable accounting standards and GEM listing rules[170]. - The group has adopted revised Hong Kong Financial Reporting Standards, which did not have a significant impact on the financial results for the period[47]. - The group continues to monitor and assess the impact of accounting estimates and assumptions on its financial reporting[46]. - The report includes significant events and transactions affecting the group's financial position and performance since the last annual report[46]. Shareholder Information - Causeway Treasure holds 427,600,560 shares, representing 53.45% of the company's equity[161]. - Chen Yongji and Chen Tianqi each own approximately 47.25% of Causeway Treasure, which is a significant shareholder in the company[161]. - The company has no plans to issue any new shares, maintaining the total issued share capital at 800,000,000 shares[94]. - No stock options were granted, lapsed, exercised, or cancelled under the company's share option scheme during the six months ended June 30, 2021[165]. - Riccardo Costi, a non-executive director, has interests in Dedem S.P.A., which operates in a competitive business area, but the company maintains independence in its operations[166]. - As of June 30, 2021, there were no other disclosures of interests or positions held by directors or senior management that could potentially conflict with the company's business[166]. Future Plans and Utilization of Proceeds - The company raised approximately HKD 62 million from the sale of 200,000,000 shares at HKD 0.31 per share, with a net amount of approximately HKD 31.85 million[173]. - As of June 30, 2021, approximately HKD 7.72 million of the net proceeds had been utilized, leaving HKD 24.13 million unutilized[174]. - The company plans to extend the timeline for utilizing the unutilized net proceeds by 12 months to December 31, 2022, due to delays in business development caused by the COVID-19 pandemic and changes in government policies[177]. - All unutilized proceeds have been deposited in a licensed bank in Hong Kong as of the mid-term report date[178].